Liver Disease Diagnostics Market

The liver is an organ about the size of a football. It sits just under your rib cage on the right side of your abdomen. The liver is essential for digesting food and ridding your body of toxic substances. Liver disease can be inherited (genetic). Liver problems can also be caused by a variety of factors that damage the liver, such as viruses, alcohol use and obesity. Over time, conditions that damage the liver can lead to scarring (cirrhosis), which can lead to liver failure, a life-threatening condition. But early treatment may give the liver time to heal.
Liver Disease Diagnostics Market contains market size and forecasts of Liver Disease Diagnostics in Global, including the following market information:
Global Liver Disease Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Liver Disease Diagnostics market was valued at 36340 million in 2021 and is projected to reach US$ 52070 million by 2028, at a CAGR of 5.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Imaging Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liver Disease Diagnostics include Abbott, Roche, Thermo Fisher Scientific, Randox Laboratories, Boston Scientific Corporation, LabCorp, Fujifilm Corporation, Horiba Medical and Siemens Healthcare GmbH. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Liver Disease Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liver Disease Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Liver Disease Diagnostics Market Segment Percentages, by Type, 2021 (%)
Imaging Tests
Blood Tests
Biopsy
Other
Global Liver Disease Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Liver Disease Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Laboratories
Others
Global Liver Disease Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Liver Disease Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liver Disease Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Liver Disease Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Roche
Thermo Fisher Scientific
Randox Laboratories
Boston Scientific Corporation
LabCorp
Fujifilm Corporation
Horiba Medical
Siemens Healthcare GmbH